Navigation Links
Activa Therapy System

ProductsActiva Therapy System
Company Medtronic Inc.
Item Activa Therapy System
Features A lead with four 1.5 mm electrodes is surgically implanted in the brain and connected by an extension that lies subcutaneously to a neurostimulator implanted near the clavicle. The electrical stimulation can be noninvasively adjusted to meet each patient's needs.
Description Activa Parkinson's Control Therapy uses electrical stimulation to safely and effectively treat some of the most disabling motor symptoms of Parkinson's disease. Activa Parkinson's Control Therapy is a safe and effective adjunctive treatment option for many Parkinson's patients. Activa Therapy controls rigidity, bradykinesia/akinesia and/or tremor while reducing the duration of dyskinesia related to antiparkinsonian medication.
Info Medtronic Inc.
Customer Service: (800) 551-5544
Web site: http://www.medtronic.com/

Related medicine products :

1. Elmed Hand Activated Monopolar Forceps
2. Bipolar Hand Activated Forceps
3. Bipolar Foot Activated Forceps
4. European Bipolar Foot Activated Forceps
5. Titanium Foot Activated Forceps
6. The Quest ACTester Activated Clotting Time System
7. Activated Protein C Resistance
8. Plasminogen Activator Inhibitor 1, Activity
9. Tissue Plasminogen Activator, Antigen
10. VISULAS 690s Photodynamic Therapy Laser System
11. VNS Therapy System
... Volk's super ... biomicroscopy lenses. Variable ... Provide unprecedented fundus ... addressing maximum potential ...
Volk indirect lenses. Wide field retinal diagnosis & treatment....
Volk indirect lenses. High magnification views of the posterior pole....
... class is particularly suitable for ... have a smaller distance between ... prism than the Haag-Streit 900, ... iridocornea. Mirror angle 59° / ...
Medicine Products:
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... ... a new partnership with the Rhode Island Consortium for Autism Research and Treatment ... opportunity for children with autism spectrum disorder (ASD) to see films in an ...
(Date:2/23/2017)... ... 2017 , ... Curemark, LLC announced today that the Blüm Study, a Phase ... 3-8 with Autism, is now enrolling at three new sites. These new sites are ... , “There are currently no approved drugs that address the core symptoms of ...
(Date:2/22/2017)... ... February 22, 2017 , ... When ... new healthcare contact center in Georgia, PENETRON Specialty Products (PSP) provided the solution. ... healthcare systems recently invested $51 million to purchase and renovate the 185,000 square-foot ...
(Date:2/22/2017)... Angeles, CA (PRWEB) , ... February 22, 2017 , ... ... detox treatment to the thousands of individuals who have recently fallen victim to America’s ... hospital in Orange County, California, where they are free from the shame, stigma, ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... leads to fewer trips the emergency room, fewer hospital admissions, and better blood ... of Managed Care® (AJMC®) finds. The study can be found here . ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... 2017 Nevro Corp. (NYSE: NVRO), a global medical ... treatment of chronic pain, today reported financial results for the ... 2016 Accomplishment & Highlights: Achieved ... increase of 228% as reported, over the prior year ... of 612% over the prior year International ...
(Date:2/23/2017)... , Feb 23, 2017 Research and Markets ... Analysis and Strategies - 2016" report to their offering. ... The latest research ... pricing data and benchmarks in the global Oesophageal Cancer market. ... What are the key drugs marketed for Oesophageal Cancer and ...
(Date:2/23/2017)... , Feb. 23, 2017 Regulus ... the discovery and development of innovative medicines targeting microRNAs, ... year 2016 financial results on Thursday, March 2, 2017 ... a conference call and webcast on March 2, 2017 ... and full year 2016 financial results and provide a ...
Breaking Medicine Technology: